News | February 11, 2008

Radiosurgery Effectively Treating Prostate Cancer, Study Says

February 12, 2008 - Accuray Inc. today announced that two- and thee-year studies on its Cyberknife radiosurgery has shown no side effects on men treated for prostate cancer and prostate specific antigen (PSA) levels showed sustained reduction during the studies.

These findings were shared at the 7th Annual CyberKnife Users' Meeting, which was held Jan. 23-27, 2008 in Scottsdale, AR.

"We're pleased that so much progress has been made demonstrating positive outcomes using the CyberKnife System as a noninvasive treatment option for prostate cancer, including durable PSA level reductions up to three years post-treatment," said Michael Santoro, M.D., attending urologist at Winthrop University Hospital's CyberKnife Radiosurgery Center.

Additionally lung cancer treatment using the CyberKnife System continued to draw a large amount of interest among the attendees with the presentation of experiences from clinicians around the world treating patients with lung tumors successfully with the CyberKnife System, said the company. During the meeting, a majority of the institutions present expressed strong interest in the prospective clinical study that is being led by M. D. Anderson Cancer Center in Houston comparing treatment outcomes with the CyberKnife System versus surgery in early-stage, operable lung cancer, according to Accuray.

Along with the enthusiasm around CyberKnife extracranial treatment results, the system remains a widely accepted tool in the treatment of brain tumors said the company. A data comparison of patients with acoustic tumors, treated by either CyberKnife or Gamma Knife radiosurgery demonstrated superior hearing preservation in the patients treated with the CyberKnife System.

According to the company, emerging CyberKnife treatment applications highlighted at the meeting demonstrated promising results treating patients with breast cancer, bone cancer, kidney cancer and various pain syndromes.

For more information: www.accuray.com

Related Content

ASTRO Applauds Introduction of PIMA Patient Protection Bill
News | Radiology Business | April 15, 2019
The American Society for Radiation Oncology (ASTRO) hailed the introduction of federal legislation that would...
Varian Discloses First Preclinical Results of Flash Therapy in Cancer Treatment
News | Proton Therapy | April 09, 2019
Varian, in partnership with the University of Maryland School of Medicine’s Department of Radiation Oncology and the...
Varian Halcyon Commissioned at MedStar Southern Maryland Hospital Center With IBA's myQA Halo
News | Quality Assurance (QA) | April 04, 2019
IBA (Ion Beam Applications S.A.) announced the successful commissioning of the Varian Halcyon at the Radiation Oncology...
Four of the top pieces of content in March included news on proton therapy, including a 360 image and videos from ITN's recent visit to the Northwestern Medicine Proton Center in the Chicago suburbs. This image shows the main proton treatment room gantry at the proton center in Warrenville, Ill. Interview with Mark Pankuch, Ph.D.

Four of the top pieces of content in March included news on proton therapy, including a 360 image and videos from ITN's recent visit to the Northwestern Medicine Proton Center in the Chicago suburbs. This image shows the main proton treatment room gantry at the proton center in Warrenville, Ill.
 

Feature | April 02, 2019 | Dave Fornell, Editor and A.J. Connell
April 2, 2019 — Here is the list of the most popular content on the Imaging Technology News (ITN) magazine w
ZON-PTC in Clinical Use With RayStation 8B and Hyperscan
News | Treatment Planning | March 19, 2019
Zuid-Oost Nederland Protonen Therapie Centrum (ZON-PTC), Maastricht, Netherlands, recently treated its first patient...
What to Expect from the Proton Therapy Market in 2019-2020
News | Proton Therapy | March 13, 2019
The number of new particle therapy rooms ordered worldwide dropped by almost 20 percent in 2018, according to a new...
Mississippi Cancer Center Combines RayStation and TomoTherapy for Prostate Cancer Case
News | Treatment Planning | March 08, 2019
Anderson Regional Cancer Center in Meridian, Miss., has treated its first patient using the combination of RaySearch's...
Videos | Proton Therapy | March 01, 2019
ITN Associate Editor Jeff Zagoudis speaks with Mark Pankuch, Ph.D., director of physics and dosimetry at the...
Videos | Proton Therapy | February 28, 2019
ITN Associate Editor Jeff Zagoudis speaks with ...